10.1248/cpb.50.1028
The study focuses on the development of a new synthetic route for the production of mono-O-protected anti-conformationally constrained pyrimidine acyclic nucleosides, which are potentially useful as antiviral and antitumoral agents, as well as tools in molecular biology. The researchers replaced 1,3-dibenzyloxypropan-2-ol with 1-benzyloxy-3(tert-butyldiphenylsilyloxy)propan-2-one (compound 4) as a key building block in the synthesis process. Various chemicals were utilized in this study, including epichlorohydrin, benzyl glycidyl ether, iodine, acetonitrile, water, tert-butylchlorodiphenylsilane, 4-N,N-dimethylaminopyridine (DMAP), pyridinium chlorochromate (PCC), n-butyllithium, tetrahydrofuran, and 2,4-dimethoxy-6-methylpyrimidine, among others. These chemicals served specific purposes in the synthesis process, such as acting as reagents, solvents, catalysts, or protecting groups, and were used in a series of reactions including ring-opening, silylation, oxidation, and dealkylation to achieve the desired nucleoside compounds with improved properties for applications in automated oligonucleotide synthesizers.